Search for European Projects

Over 40 European Projects Found

Searched on 125080 European Projects

 ONGOING 
... tal health measures for extensively broader cohorts, exceeding 40.000 examinations in total. By linking these data, also to additional databases and biobanks, including birth registries, national and regional archives, and by enriching them with new online data collection and novel measures, we will address risk and protective factors of brain, cognitive and mental health throughout the lifespan. ...
Read Project

 16

 ONGOING 

European Human Biomonitoring Initiative (HBM4EU)

Start date: Jan 1, 2017, End date: Dec 31, 2021,

The overarching goal of the European Human Biomonitoring Initiative (HBM4EU) is to generate knowledge to inform the safe management of chemicals and so protect human health. We will use human biomonitoring to understand human exposure to chemicals and resulting health impacts and will communicate with policy makers to ensure that our results are exploited in the design of new chemicals policies an ...
Read Project

 43

 ONGOING 
Sudden cardiac arrest (SCA) causes ~20% of all deaths in Europe. SCA is lethal within minutes if left untreated and survival rates are presently only 5-20%. Therefore, there is a large medical need to improve SCA prevention and treatment. Designing effective individualized prevention and treatment strategies requires knowledge on genetic and environmental risk factors. So far, these efforts have b ...
Read Project

 17

 ONGOING 
... ational scope, all elements involved in these responses will be addressed in this project, from detailed analysis of food items responsible for hormone secretion, to identification of the responsible regions of the gut, and to the molecular mechanisms leading to hypersecretion. Novel approaches for studies of human gut hormone secreting cells, including specific expression analysis, are combined w ...
Read Project

 2

 ONGOING 
The complex interactions between genetic and non-genetic factors produce heterogeneities in patients as reflected in the diversity of pathophysiology, clinical manifestations, response to therapies, disease development and progression. Yet, the full potential of personalized medicine entails biomarker-guided delivery of efficient therapies in stratified patient populations.MultipleMS will therefor ...
Read Project

 25

 ONGOING 
Chronic aortic aneurysms are permanent and localized dilations of the aorta that remain asymptomatic for long periods of time but continue to increase in diameter before they eventually rupture. Left untreated, the patients’ prognosis is dismal, since the internal bleeding of the rupture brings about sudden death. Although successful treatment cures the disease, the risky procedures can result in ...
Read Project

 26

 ONGOING 
Chronic angina pectoris is a debilitating chronic disease, a subgroup of these patients suffers from refractory angina which unfortunately can’t be controlled by medical therapy (angioplasty or surgery). Refractory angina is a substantial burden on the individual and healthcare system, in Europe there are 100,000 new cases per year, annual mortality of these patients is relatively low (
Read Project

 10

 ONGOING 

RECAP: Research on European Children and Adults born Preterm (RECAP)

Start date: Jan 1, 2017, End date: Mar 31, 2021,

The project’s overall aim is to improve the health, development and quality of life of children and adults born very preterm (VPT, < 32 weeks of gestation) or very low birth weight (VLBW, < 1500g) – approximately 50 000 births each year in Europe – by establishing an ICT platform to integrate, harmonise and exploit the wealth of data from 20 European cohorts of VPT/VLBW children and adults and the ...
Read Project

 21

 ONGOING 
Companion diagnostics are crucial for drug development and disease management with regard to patient selection, therapy planning and monitoring. Nanomedicines such as antibodies have been proven to be optimal disease-targeting agents because they generally exhibit superior target uptake and retention. However, to date, nuclear imaging of nanomedicines has been limited to the use of long-lived isot ...
Read Project

 6

 ONGOING 
COSYN integrates outstanding European academic and three large Pharma to exploit genomic findings for intellectual disability (ID), autism, and schizophrenia. We capitalise on comorbidity, from clinic to cells and synapses, and have access to large existing samples. We focus on rare genetic variants of strong effect in patients with clinical comorbidity. Our aims are: (1) Understand comorbidity by ...
Read Project

 14

 ONGOING 

Technology Enabled Adolescent Mental Health (TEAM)

Start date: Nov 1, 2016, End date: Oct 31, 2020,

There is no health without mental health. 27% of our population are young, and mental health disorders are our leading cause of disability. 50% of mental disorders emerge by 14 yrs, 75% by 24 yrs and, untreated, triple odds of having a mental health disorder in later life. TEAM’s will build a network of expertise and train a new generation of researchers to deliver more effective, affordable and f ...
Read Project

 9

 ONGOING 
For practice of personalized medicine in cancer, non-invasive tools for diagnosing at the molecular level are needed. Molecular imaging methods are capable of this while at the same time circumventing sampling error as the whole tumor burden is evaluated.We recently developed and performed the first-ever clinical PET scan of uPAR, a proteolytic system known to be strongly associated with metastati ...
Read Project

 1

 ONGOING 

Breast Cancer Risk after Diagnostic Gene Sequencing (BRIDGES) (BRIDGES)

Start date: Sep 1, 2015, End date: Aug 31, 2020,

Breast cancer affects more than 360,000 women per year in the EU and causes more than 90,000 deaths. Identification of women at high risk of the disease can lead to disease prevention through intensive screening, chemoprevention or prophylactic surgery. Breast cancer risk is determined by a combination of genetic and lifestyle risk factors. The advent of next generation sequencing has opened up th ...
Read Project

 20

 ONGOING 
Thousands of sites across Europe are polluted with toxic metals and organic solvents; many more exist worldwide. As EU population grows, clean water will determine the quality of life and economic stability. Most sites remain contaminated because existing technology is costly and disruptive. Society needs an innovative way to decontaminate soil and groundwater directly underground. In METAL-AID, w ...
Read Project

 11

 ONGOING 
Traumatic Brain Injury (TBI) is a major cause of death and disability, leading to great personal suffering to victim and relatives, as well as huge direct and indirect costs to society. Strong ethical, medical, social and health economic reasons therefore exist for improving treatment. The CENTER-TBI project will collect a prospective, contemporary, highly granular, observational dataset of 5400 p ...
Read Project

 44

 ONGOING 

Evidence-based ICT tools for weight loss maintenance (NoHoW)

Start date: Mar 1, 2015, End date: Feb 29, 2020,

Most adults who try to lose weight fail to maintain it. Obesity is a key economic and healthcare challenge for Europe. Effective interventions and commercial programmes for weight loss are widely available, but most people re-gain their lost weight. Currently few comprehensive solutions exist to help Europeans manage weight loss maintenance (WLM).Current research suggests the most promising eviden ...
Read Project

 16

 ONGOING 
Abstract 9Neuroimaging (NI) has enormous potential to improve the clinical care of patients with psychiatric disorders, but has yet to deliver. The PSYSCAN project will address this issue directly by developing a NI-based tool that will help clinicians resolve key clinical issues in the management of patients with psychotic disorders. Clinicians will use the tool to assess patients with a standard ...
Read Project

 24

 ONGOING 

European Gram Negative Antibacterial Engine (ENABLE)

Start date: Feb 1, 2014, End date: Jan 31, 2020,

The intensive use and misuse of antibiotics has resulted in some level of antibiotic resistance in essentially all human bacterial pathogens. There is a growing concern that the loss of therapeutic options will present us with a post-antibiotic era where present and future medical advances are negated. Resistant bacteria dramatically reduce the possibilities of treating infections effectively, a ...
Read Project

 42

 ONGOING 
Up to 70% of cardiovascular events are not prevented by current therapeutic regimens. In search for additional, innovative strategies, immune cells have been recognized as key players contributing to atherosclerotic plaque progression and destabilization. Particularly the role of innate immune cells is of major interest, following the recent paradigm shift that innate immunity, considered to be in ...
Read Project

 11

 ONGOING 
RUBICON will establish a global network for staff exchange of scientists and for research training focussed on connective tissue disorders. It will bring together leading scientific groups from 5 European and 5 non-European countries who will study the molecular and biomechanical factors involved in the pathophysiology of connective tissues, including tendons, cartilage and bone. The ambitious obj ...
Read Project

 5

 ONGOING 
Stem Cell therapy in IschEmic Non-treatable Cardiac diseasE (SCIENCE)With more than 17 million deaths worldwide each year, ischemic heart disease (IHD) caused by coronary artery disease is the most common cause of death and a major cause of hospital admissions in industrialised countries. IHD caused over four million deaths in Europe in the year 2012 constituting 47% of all deaths. Today IHD is th ...
Read Project

 9

 ONGOING 
The project GALAHAD targets the critical need for better glaucoma diagnostic systems. Glaucoma is an age-related major cause of blindness. The eye disease is characterized by an irreversible damage to the optic nerve head caused by increased intra-ocular pressure. The current screening and basic diagnostics for the disease involve intra-ocular pressure measurement, visual field tests and detection ...
Read Project

 10

 ONGOING 

Training Network for the Immunotherapy of Cancer (IMMUTRAIN)

Start date: Dec 1, 2015, End date: Nov 30, 2019,

In the European Union, cancer is the leading cause of death and the overall cancer incidence is still increasing. As a result of expanding efforts to improve cancer outcome, a main paradigm change is occurring in cancer therapy towards individualized medicine. Antibody-based therapies form an integral and constantly growing part of this approach. Antibody-based therapies will strongly influence th ...
Read Project

 9

 ONGOING 
Lifestyle factors of the patient (e.g. smoking, hazardous alcohol drinking and malnutrition) are proven to be independent risk factors negatively impacting health outcome in the perioperative process. Evidence suggests that the implementation of intensive lifestyle intervention programs can significantly reduce the post-surgery complication risk and rehabilitation time . However, implementation of ...
Read Project

 4

 FINISHED 
Cardiovascular diseases (CVD) cause over 4 million deaths in Europe each year and mass disability: within the coming decades the disability-adjusted life years (DALYs) estimate is expected to rise from a loss of 85 million DALYs in 1990 to a loss of 150 million DALYs globally in 2020. Moreover, patient numbers are expected to rise rapidly in the next decades, due to an ageing society such that th ...
Read Project

 11

 FINISHED 
The Gluco-Psychosocial Axis (GPA) concerns the interplay of factors determining glucose metabolism and insulin sensitivity and the neuroendocrine response resulting from exposure to psychosocial stress. A sub-optimal GPA influences the development of type 2 diabetes and related impairments with varying degrees of interplay between genetics and early growth (particularly adiposity and cognitive fun ...
Read Project

 14

 FINISHED 
Coronary artery disease (CAD) is the leading cause of death in high-income countries. Invasive coronary angiography (ICA) is the reference standard for the diagnosis of CAD and allows immediate therapy. However, only 40% of patients undergoing ICA actually have obstructive CAD and ICA has relatively rare but considerable risks. Coronary computed tomography (CT) is the most accurate diagnostic test ...
Read Project

 38

 FINISHED 
Today there is no regenerative therapy available for treatment of complete spinal cord injuries (SCI). BioArctic Neuroscience develops a novel treatment of complete SCI. The method is based on the regeneration of functional nerves in the injured spinal cord. Nerve grafts are transplanted into the injured spinal cord, by using a biodegradable device, loaded with a growth factor and nerve grafts (th ...
Read Project

 6

 FINISHED 

Targeted Action for Curing Trauma Induced Coagulopathy (TACTIC)

Start date: Nov 1, 2013, End date: Oct 31, 2018,

"Trauma remains one of the world’s biggest contributors to the global burden of disease. Predominantly affecting young adults and children, 800,000 European injury related deaths were recorded in 2002. Outcomes for critically injured trauma patients remain poor with severe bleeding, brain injury and tissue damage being associated with high mortality and disability. Nearly half of all trauma fatali ...
Read Project

 9

 FINISHED 
... technology from EU member states and the US to new contexts and explore a range of implementation science research questions. The new knowledge this generates will be widely disseminated nationally, regionally and internationally, ensuring the scale-up of interventions tested by the project and global impact of research findings. The project will also provide new perspectives on policy issues of ...
Read Project

 15

 FINISHED 

Pan-European Professional Curriculum for Gynaecologists

Start date: Sep 1, 2015, End date: Aug 31, 2018,

In Europe there are more than 5 million births each year and about 2 million women have failed pregnancies. Maternal deaths associated with pregnancy and delivery are as high as 30/100.000 births, of which 50% are linked to substandard care. Furthermore about 25.000 babies are stillborn every year and another 25.000 die before their 1st birthday. There are only a few EU-wide agreed health indica ...
Read Project

 10

 FINISHED 

Screening to improve Health In very Preterm infantS in Europe (SHIPS)

Start date: Sep 1, 2015, End date: Aug 31, 2018,

... time input from families. This project uses a unique resource – the EPICE cohort of 6675 babies born before 32 weeks of gestational age and surviving to discharge home in 18 geographically diverse regions in 2011/2012 – to assess the impact of these screening programmes on health, care and quality of life for very preterm infants and their families as well as on coverage, ability to meet needs, h ...
Read Project

 15

 FINISHED 

Translating disease to cardiovascular health (TransCard)

Start date: Sep 1, 2013, End date: Aug 31, 2018,

Cardiovascular disease (CVD) is the leading cause of death in Europe and the world. Drugs that lower cholesterol in blood are the most efficient drugs used to date but we are currently still facing a 50-70% residual risk of suffering from CVD. This clearly illustrates an urgent need for the identification, characterization and validation of novel therapeutically relevant targets. Over the last dec ...
Read Project

 8

 FINISHED 

Leiðbeinendur nemenda og nýráðinna

Start date: Jun 30, 2016, End date: Jun 29, 2018,

Every year there are 1600 students in vocational training at the University Hospital. In addition, approximately 150 people recently graduated start working at the hospital. The role of the University Hospital as an educational organisation must be strengthened to contribute to effective learning and successful start in the labour market. Department of Education at the University Hospital is respo ...
Read Project

 5

 FINISHED 
Despite the fact that iodine deficiency (ID) can easily be prevented by iodine fortification of table salt, industrial salt and cattle food, Europe belongs to the worst regions in terms of access to iodized salt and is seriously ID, resulting in the perpetuation of the single most important, preventable cause of brain damage. European ID is due to significant heterogeneity in prevention and monito ...
Read Project

 33

 FINISHED 

SPP Regions

Start date: Apr 1, 2015, End date: Mar 31, 2018,

The SPP Regions project is aimed at promoting strong networking and collaboration at both the European and sub-national regional level on sustainable and innovative procurement (SPP/PPI), to help promote and embed capacity building and knowledge transfer. At the regional level networking will be promoted to build capacities and transfer skills in sustainable and innovative procurement implementati ...
Read Project

 14

 FINISHED 

eHealth in Rheumatology (ELECTOR)

Start date: Jan 1, 2015, End date: Mar 31, 2018,

The increasing number of chronic patients in rheumatology calls for further development of the traditional methods for monitoring symptoms. The aim of the ELECTOR project is to develop a web-based ICT platform for home-based monitoring of self-reliant patients with rheumatoid arthritis. This will provide clinicians with a tool that can completely substitute a large proportion of the conventional v ...
Read Project

 8

 FINISHED 
... revious successful Virtual Physiological Human (VPH) projects. An existing decision support tool is enhanced to meet the needs of clinical practice and validated in real conditions across several EU regions. The first goal is to show that modern computer-based models enable earlier and more objective clinical diagnostics. The second goal is to improve cost-efficiency of early diagnostics by devel ...
Read Project

 10

 FINISHED 
... IA project is designed to expand ECRIN partnerships and impact beyond this core activity.Networking activities will promote pan-European expansion, capacity building, and partnership with other world regions, and address the funding issue (WP2). ECRIN-IA will develop e-services, education material to train professionals and patients associations, and communication with users, patients, citizens an ...
Read Project

 48

 FINISHED 
The overall goal with INFECT is to advance our understanding of the pathophysiological mechanisms, prognosis, and diagnosis of the multifactorial highly lethal NSTIs. The fulminant course of NSTIs (in the order of hours) demands immediate diagnosis and adequate interventions in order to salvage lives and limbs. However, diagnosis and management are difficult due to heterogeneity in clinical presen ...
Read Project

 16